{"id":"W2978917127","doi":"10.14309/00000434-200410001-00827","title":"EFFICACY ASSESSMENT OF NATALIZUMAB IN PATIENTS WITH CROHNʼS DISEASE AND PRIOR HISTORY OF INFLIXIMAB THERAPY","year":2004,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Natalizumab; Medicine; Randomized controlled trial; Internal medicine; Infliximab; Crohn's disease; Placebo; Clinical endpoint; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001562968,0.000290258,0.00108048,0.0002574585,0.0002095989,0.000331545,0.000207727,0.000339837,0.0009257857],"category_scores_gemma":[0.001830889,0.0001540973,0.0005829645,0.0002112201,0.0002078211,0.0002808374,0.0001914755,0.0004914918,0.0001297175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003111852,"about_ca_system_score_gemma":0.0003107639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000323695,"about_ca_topic_score_gemma":0.0009073465,"domain_scores_codex":[0.9994395,0.000269597,0.00007430943,0.00007187798,0.0001041385,0.00004051844],"domain_scores_gemma":[0.9987947,0.0003969288,0.000493879,0.00004623753,0.00006980626,0.0001985262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3375489,0.005018434,0.5068277,0.001320536,0.002906505,0.0005380885,0.000273356,0.001347459,0.01093932,0.0001397633,0.0009540271,0.1321859],"study_design_scores_gemma":[0.03438279,0.1257983,0.8264551,0.0001795342,0.002178179,0.001498878,0.0001527384,0.002123705,0.002554826,0.0001286462,0.004508903,0.00003838844],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937528,0.005052182,0.0001099144,0.0001573637,0.00003804003,0.00009389908,0.0001195612,0.0000054653,0.0006709183],"genre_scores_gemma":[0.9984789,0.000761857,0.0001787282,0.0001195547,0.00005851924,0.00006323312,0.0001753493,8.276226e-7,0.0001629122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001562968,"threshold_uncertainty_score":0.008265853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004103712544955102,"score_gpt":0.2249090649440288,"score_spread":0.2208053523990738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}